Latest Articles

Publication Date
Rosalind Franklin University Leader in Reproductive Immunology to Speak at the 2025 American Society of Reproductive Medicine Congress - Morningstar

Rosalind Franklin University Leader in Reproductive Immunology to Speak at the 2025 American Society of Reproductive Medicine Congress Morningstar

Published: Oct. 29, 2025, 5:27 p.m.
Repetition Makes You Stronger - Deccan Chronicle

Repetition Makes You Stronger Deccan Chronicle

Published: Oct. 29, 2025, 3:42 p.m.
Will GDHG stock benefit from AI adoption - Quarterly Trade Report & High Accuracy Swing Entry Alerts - Fundação Cultural do Pará

Will GDHG stock benefit from AI adoption - Quarterly Trade Report & High Accuracy Swing Entry Alerts Fundação Cultural do Pará

Published: Oct. 28, 2025, 8:30 p.m.
The pain women keep being told to ignore: Why pelvic pain is not always endometriosis - India TV News

The pain women keep being told to ignore: Why pelvic pain is not always endometriosis India TV News

Published: Oct. 28, 2025, 9:50 a.m.
Risk factors for postoperative recurrence of deep infiltrating endometriosis during a 6- to 12-year follow-up - Nature

Risk factors for postoperative recurrence of deep infiltrating endometriosis during a 6- to 12-year follow-up Nature

Published: Oct. 28, 2025, 8:59 a.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - BioSpace

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer BioSpace

Published: Oct. 28, 2025, 5:03 a.m.
Why the Women’s Health Space Needs to Expand Beyond Reproductive Health - MedCity News

Why the Women’s Health Space Needs to Expand Beyond Reproductive Health MedCity News

Published: Oct. 27, 2025, 10:24 p.m.
Monday's Health Report: What is endometriosis and how can it affect your life? - WBRZ

Monday's Health Report: What is endometriosis and how can it affect your life? WBRZ

Published: Oct. 27, 2025, 9:02 p.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - The AI Journal

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer The AI Journal

Published: Oct. 27, 2025, 7:50 p.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - Yahoo Finance

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer Yahoo Finance

Published: Oct. 27, 2025, 7:33 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!